These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 7509251)

  • 21. Pro-gastrin-releasing peptide (ProGRP) and neuron specific enolase (NSE) in therapy control of patients with small-cell lung cancer.
    Schneider J; Philipp M; Salewski L; Velcovsky HG
    Clin Lab; 2003; 49(1-2):35-42. PubMed ID: 12593474
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical course of chronic hepatitis C in patients with very high serum alpha-fetoprotein levels and normal hepatic imaging.
    Gonzalez SA; Jacobson IM
    Am J Gastroenterol; 2005 Apr; 100(4):977-8. PubMed ID: 15784045
    [No Abstract]   [Full Text] [Related]  

  • 23. Diagnostic value of CEA, CYFRA 21-1, NSE and CA 125 assay in serum and pleural effusion of patients with lung cancer.
    Wu GP; Ba J; Zhao YJ; Wang EH
    Acta Cytol; 2007; 51(4):679-80. PubMed ID: 17718156
    [No Abstract]   [Full Text] [Related]  

  • 24. [Which tumor markers should be used in primary bronchial cancers?].
    Schuller MP; Carrat F; Urban T; Lebeau B
    Rev Mal Respir; 1997 Apr; 14 Suppl 3():S9-14. PubMed ID: 9229750
    [No Abstract]   [Full Text] [Related]  

  • 25. [Chylous ascites as a form of presentation of gastric cancer].
    Félix Rodríguez-Vidigal F; Puerto-Pica JM; Sánchez-Trenado JM; Cabanillas Y; Pérez-Miranda M
    An Med Interna; 2000 Feb; 17(2):107. PubMed ID: 10829473
    [No Abstract]   [Full Text] [Related]  

  • 26. [Tumor markers in the diagnosis of lung cancer].
    Marel M; Bíbrová L; Melínová L; Potocková L; Svandová E
    Cas Lek Cesk; 1993 Feb; 132(4):108-12. PubMed ID: 7682476
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Neuron-specific enolase as a tumor marker].
    Biran H
    Harefuah; 1994 Dec; 127(11):500-2. PubMed ID: 7806116
    [No Abstract]   [Full Text] [Related]  

  • 28. [Value of serial tumor markers for the detection of recurrences].
    Quoix E
    Rev Mal Respir; 1997 Apr; 14 Suppl 3():S27-9. PubMed ID: 9229745
    [No Abstract]   [Full Text] [Related]  

  • 29. [Clinical evaluation of several tumor markers in the chest surgery].
    Miyazato I; Tojo N
    Rinsho Kyobu Geka; 1988 Jun; 8(3):231-6. PubMed ID: 9301836
    [No Abstract]   [Full Text] [Related]  

  • 30. Use of common seric tumor markers in patients with solid cancers.
    Gara S; Boussen H; Ghanem A; Guemira F
    Tunis Med; 2008 Jun; 86(6):579-83. PubMed ID: 19216452
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Des-gamma carboxy prothrombin (PIVKA-II)- and alpha-fetoprotein (AFP)-producing gastric cancer.
    Takahashi Y; Endo H; Tange T; Kurabayashi R; Nomura S; Kaminishi M; Tange T
    J Gastroenterol; 2005 Apr; 40(4):432-3. PubMed ID: 15870980
    [No Abstract]   [Full Text] [Related]  

  • 32. [Neuron specific enolase].
    Milleron B
    Rev Mal Respir; 1997 Apr; 14 Suppl 3():S36-7. PubMed ID: 9229748
    [No Abstract]   [Full Text] [Related]  

  • 33. The use of serologic tumor markers in gastrointestinal malignancies.
    Posner MR; Mayer RJ
    Hematol Oncol Clin North Am; 1994 Jun; 8(3):533-53. PubMed ID: 8707771
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Value of serial tumor markers for determining the prognosis and predicting treatment response and survival].
    Souquet PJ
    Rev Mal Respir; 1997 Apr; 14 Suppl 3():S20-2. PubMed ID: 9229743
    [No Abstract]   [Full Text] [Related]  

  • 35. Usefulness of a multiple biomarker assay in bronchoalveolar lavage (BAL) and serum for the diagnosis of small cell lung cancer.
    Nikliński J; Chyczewska E; Furman M; Kowal E; Laudanski J; Chyczewski L
    Neoplasma; 1993; 40(5):305-8. PubMed ID: 8272160
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Soluble interleukin-2 receptors (sIL-2R) and neuron specific enolase (NSE) in small cell lung carcinoma.
    Sarandakou A; Poulakis N; Rizos D; Trakakis E; Phocas I
    Anticancer Res; 1993; 13(1):173-5. PubMed ID: 8386493
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multiple tumour markers for diagnosis, management and follow-up of potentially resectable lung cancer.
    Ratto GB; Mereu C; Rovida S
    Panminerva Med; 1993 Dec; 35(4):186-92. PubMed ID: 8202329
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Focus on a new assay of fucosylated alpha-fetoprotein and evaluation in the biological diagnosis of hepatocellular carcinoma in cirrhosis].
    Denis I; Beaudonnet A; Pichot J; Roubille M; Gelineau M
    Ann Biol Clin (Paris); 2000; 58(1):85-90. PubMed ID: 10673618
    [No Abstract]   [Full Text] [Related]  

  • 39. [Tumor markers in cancer of the digestive system].
    Zinser JW
    Rev Gastroenterol Mex; 1997; 62(3):145-8. PubMed ID: 9480520
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Study of the hormone-refractory prostate cancer clinical practice in an anti-cancer center].
    Zufferey L; Roques B; Fléchon A; Droz JP
    Bull Cancer; 2001 Dec; 88(12):1213-21. PubMed ID: 11792613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.